Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non–small-cell Lung Cancer
Clinical Lung Cancer（2018）
Key words
Crizotinib,IRF2BP2,NSCLC,NTRK fusion,Pan-TRK inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined